FDA Biotech Fellowship Places Fellows At Curia And OPQ Office

A structured talent pipeline connecting PharmD graduates directly to CDMO operations and federal manufacturing oversight is taking shape through the FDA's Regulatory Pharmaceutical Fellowship Program, with the biopharmaceutical manufacturing track drawing particular relevance for QA directors and plant heads navigating a tightening regulatory science workforce.

Administered in partnership with Albany College of Pharmacy and Health Sciences, the two-year biopharmaceutical manufacturing track rotates fellows across three settings: four months at Albany's Stack Family Center for Biopharmaceutical Education and Training (CBET), twelve months embedded at Curia Global across contract research, development, and manufacturing operations, and eight months at FDA's Office of Pharmaceutical Manufacturing Assessment within the Office of Pharmaceutical Quality in Silver Spring, MD. The sequencing is deliberate, fellows move from academic grounding into CDMO production environments before transitioning into the regulatory assessment function that reviews manufacturing submissions.

For operations and regulatory affairs leads at CDMOs and sponsor companies, the structure signals where FDA expects future manufacturing assessors to build their competency base: inside commercial GMP facilities, not solely in government or academic settings. Fellows who complete the program are positioned to enter careers in any of the three practice settings, meaning the cohort feeds talent simultaneously into industry QA functions, academic training programs, and FDA's own manufacturing review offices.

The program currently spans six tracks, including regulatory affairs and policy, regulatory science, medication safety, drug information, and drug advertising and promotion, with industry partners including Johnson & Johnson and Eli Lilly anchoring rotations in those respective tracks. Recruitment for the biopharmaceutical manufacturing track is not currently open; October 2026 is the indicated window to check for updated application timelines and eligibility criteria via Albany College of Pharmacy and Health Sciences.

For regulatory affairs leads monitoring workforce trends within the Office of Pharmaceutical Quality, the fellowship's manufacturing-heavy rotation structure reflects a continued institutional emphasis on assessors who carry direct GMP site experience into the review process.

Source: U.S. Food and Drug Administration (FDA) via FDA.gov What's New: Drugs RSS Feed, October 1, 2026.